Compound Detail
CHEMBL4855061
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4855061 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WALGIFGEBJFLLP-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
330.4
MW (Da)
4.46
ALogP
5
HBA
3
HBD
78.5
PSA (Ų)
0.51
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.11
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 6.11 | 6.11 | 770.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.18 | 5.18 | 6600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 770.0 | nM | 6.11 | Antimalarial activity against chloroquine-sensitive plasmodium falciparum 3D7 in... | 34479064 |
| HepG2 | IC50 | = | 6600.0 | nM | 5.18 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth mea... | 34479064 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34479064 | 10.1016/j.bmc.2021.116348 | Plasmodium falciparum | 1 |
| 34479064 | 10.1016/j.bmc.2021.116348 | HepG2 | 1 |
| 34479064 | 10.1016/j.bmc.2021.116348 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine